MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis

Completed
Conditions
Breast Screening
Interventions
Procedure: breast ultrasound
Procedure: DBT (Full field digital mammography + tomosynthesis)
First Posted Date
2014-06-25
Last Posted Date
2023-01-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
1494
Registration Number
NCT02174406
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2014-06-19
Last Posted Date
2021-07-09
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
23
Registration Number
NCT02167854
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Not Applicable
Active, not recruiting
Conditions
Proximal Femoral Metastases
Interventions
Procedure: long-stem cemented hemiarthroplasty (LSCH)
Procedure: intramedullary nailing (IMN)
Behavioral: questionnaires
First Posted Date
2014-06-16
Last Posted Date
2024-07-03
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
73
Registration Number
NCT02164019
Locations
πŸ‡ΊπŸ‡Έ

University of Rochester Medical Center, Rochester, New York, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York, United States

πŸ‡ΊπŸ‡Έ

SUNY Upstate Medical University, Syracuse, New York, United States

and more 3 locations

Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation

Phase 2
Terminated
Conditions
Rectal Cancer
for Bowel Dysfunction Following Surgery for Rectal Cancers
Interventions
Device: Implantation of the InterStimTM
Behavioral: MSK BFI questionnaires
Behavioral: The Low Anterior Resection Score (LARS) questionnaires
Behavioral: The EuroQOL5D questionnaires
Behavioral: The Fecal incontinence Quality of Life Scale (FIQOL) questionnaires
First Posted Date
2014-06-13
Last Posted Date
2018-02-05
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
4
Registration Number
NCT02163187
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Weill Medical College of Cornell University, New York, New York, United States

Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib

Phase 1
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2014-06-04
Last Posted Date
2019-01-16
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
22
Registration Number
NCT02155465
Locations
πŸ‡ΊπŸ‡Έ

Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Memoral Sloan Kettering Cancer Center at Phelps, Sleepy Hollow, New York, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 3 locations

Development of Psychotherapeutic Interventions for Parents Who Lost a Child

Not Applicable
Active, not recruiting
Conditions
Parents Who Have Lost a Child
Interventions
Behavioral: Meaning-Centered Grief Therapy (MCGT)
Behavioral: questionnaires assessments
Behavioral: Supportive Psychotherapy (SP)
First Posted Date
2014-06-03
Last Posted Date
2025-06-03
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
108
Registration Number
NCT02153619
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Phase 3
Completed
Conditions
Bladder Cancer
Interventions
Other: standard fluid management
Other: fluid management guided by the EV1000
First Posted Date
2014-05-23
Last Posted Date
2024-03-20
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
282
Registration Number
NCT02145871
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, United States

and more 2 locations

Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study

Early Phase 1
Completed
Conditions
Thyroid Carcinoma
Interventions
First Posted Date
2014-05-22
Last Posted Date
2025-06-18
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
12
Registration Number
NCT02145143
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Not Applicable
Completed
Conditions
Ovarian Cancer
Interventions
Procedure: PET/CT Scan
Procedure: MRI
First Posted Date
2014-05-22
Last Posted Date
2020-06-18
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
26
Registration Number
NCT02144311
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering West Harrison, Harrison, New York, United States

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Not Applicable
Withdrawn
Conditions
Histologically-confirmed Malignancies
Interventions
Radiation: [18F] FLT
Device: PET/CT scans
First Posted Date
2014-05-15
Last Posted Date
2019-09-17
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Registration Number
NCT02139150
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath